InvestSMART

Vitura Health Limited (ASX:VIT)

ALERT: Price-sensitive ASX Announcement for VIT
Current share price for VIT : $0.019 -0.012 (-38.71%)+
Announcement
Release
26 Aug 2026 9:35AM
Price at Release
$0.031
Full Release
download
Summary
Vitura Health Limited reported its FY2026 financial results, highlighting a year of solid revenue growth but significant challenges, including a net loss of $4.4 million and a decline in normalised EBITDA by 66.3%. Total revenue increased to $131.2 million, driven by growth in medicinal cannabis and nicotine vaping products. However, intensified competition and price discounting pressured margins. The company underwent significant leadership changes with a new CEO, Justin James, and implemented a leaner leadership structure saving $1 million annually, aiming to transition from a startup mindset to a mature and disciplined organization. This shift is focused on improving earnings quality, sustainable value creation, and setting a foundation for future profitability, with early FY2027 results showing positive signs.
Key Points
  • Total revenue increased by 5.7% to $131.2 million.
  • Net loss after tax of $4.4 million compared to a $3.1 million profit in FY2025.
  • Normalised EBITDA decreased by 66.3% to $3.0 million.
  • Leader transition with new CEO, CFO, and strategy head.
  • Implemented cost-saving measures and leaner leadership structure.
  • Focus on earnings quality and sustainable value creation.
  • Medicinal cannabis and nicotine vaping products sales increased.
  • Plans to enhance shareholder value and return to profitability.
  • Positive outlook for FY2027 with improvements in financial metrics.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.